Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ovusitol D is a dietary supplement specifically formulated to support the nutritional requirements of women during the preconception period and pregnancy. It contains a combination of myo-inositol, folic acid, and Vitamin D. Myo-inositol, a member of the B-vitamin complex, plays a significant role in insulin signaling and has been shown to improve oocyte quality and ovulation frequency, particularly in women with Polycystic Ovary Syndrome (PCOS). Folic acid is essential for cell division and DNA synthesis, and its supplementation is critical for preventing neural tube defects in the developing fetus. Vitamin D is included to support bone health, immune function, and overall healthy pregnancy outcomes. The product is manufactured by Italfármaco and is marketed and distributed by Laboratorios Mallén in regions including the Dominican Republic and Central America.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ovusitol D.